Innovation Pharmaceuticals competitorsClear all

Innovation Pharmaceuticals's top competitors include Urovant Sciences, Heron Therapeutics, Thesan Pharmaceuticals and Immatics.
Innovation Pharmaceuticals
Innovation Pharmaceuticals
Innovation Pharmaceuticals is engaged in developing therapies with oncology, dermatology and antimicrobial applications.
Urovant Sciences
Urovant Sciences
Urovant Sciences is a biopharmaceutical company focused on developing novel therapies for urologic conditions.
Heron Therapeutics
Heron Therapeutics
Heron Therapeutics is a specialty pharmaceutical company developing pharmaceutical products using its Biochronomer polymer-based drug delivery platform.
Thesan Pharmaceuticals
Thesan Pharmaceuticals
Thesan Pharmaceuticals is a preclinical biopharmaceutical company developing novel therapeutics for skin disorders.
Immatics
Immatics
Immatics is a biotechnology company that is primarily engaged in the research and development of T cell redirecting immunotherapies for the treatment of cancer.
Founding Date
Founding Date
2007
Founding Date
2016
Founding Date
1983
Founding Date
2011
Founding Date
2000
Type
Type
Public
Type
Public
Type
Public
Type
Private
Type
Public
Tags
Locations
Locations
Wakefield, US HQ
Beverly, US
Locations
Irvine, US HQ
Basel, CH
Locations
San Diego, US HQ
Jersey City, US
Locations
Carlsbad, US HQ
Locations
Tübingen, DE HQ
München, DE
Houston, US
Employees
Employees
450% decrease
Employees
3950% increase
Employees
23117% increase
Employees
1
Employees
230
Valuation ($)
Valuation ($)
134.5 m
Valuation ($)
529.5 m
Valuation ($)
1.6 b
Valuation ($)
N/A
Valuation ($)
705.2 m
Twitter followers
Twitter followers
180
Twitter followers
115
Twitter followers
N/A
Twitter followers
N/A
Twitter followers
1.1 k
Number of tweets (last 30 days)
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
9
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
17
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
2.1
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
4.4
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
100%
Alexa Website Rank
Alexa Website Rank
226808
Alexa Website Rank
450870
Alexa Website Rank
354402
Alexa Website Rank
363256
Alexa Website Rank
252172

Financial

Revenue (est.)
Revenue (est.)
$423k (FY, 2020)
Revenue (est.)
N/A
Revenue (est.)
$88.6m (FY, 2020)
Revenue (est.)
N/A
Revenue (est.)
€18.4m (FY, 2019)
Net income
Net income
($6.6m) (FY, 2020)
Net income
($146.7m) (FY, 2020)
Net income
($227.3m) (FY, 2020)
Net income
N/A
Net income
(€32.5m) (FY, 2019)

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 65m
Total funding raised
$ 267.3m
For sources of this data, please see the company profile

View company profiles

Urovant Sciences
HQ
Irvine, US
Employees
39↑ 50% increase

Urovant Sciences is a biopharmaceutical company focused on developing novel therapies for urologic conditions.

View company
Heron Therapeutics
HQ
San Diego, US
Employees
231↑ 17% increase

Heron Therapeutics is a specialty pharmaceutical company developing pharmaceutical products using its Biochronomer polymer-based drug delivery platform.

View company
Thesan Pharmaceuticals
HQ
Carlsbad, US
Employees
1

Thesan Pharmaceuticals is a preclinical biopharmaceutical company developing novel therapeutics for skin disorders.

View company
Immatics
HQ
Tübingen, DE
Employees
230

Immatics is a biotechnology company that is primarily engaged in the research and development of T cell redirecting immunotherapies for the treatment of cancer.

View company